# NAN FUNG TRINITY (HK) LTD

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1781880. Source: https://holderbook.com/funds/1781880-nan-fung-trinity-hk-ltd/

- Reported value: $1.0B
- Positions: 55
- Weight of the ten largest: 40.5%
- Filed: 2026-07-24

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| ADVANCED MICRO DEVICES INC | [AMD](https://holderbook.com/stocks/AMD/) | $67.8M | 116,700 | 6.7% | 4 |
| AMCOR PLC | [AMCR](https://holderbook.com/stocks/AMCR/) | $52.0M | 1,199,576 | 5.1% | 2 |
| PPG INDS INC | [PPG](https://holderbook.com/stocks/PPG/) | $48.2M | 397,334 | 4.8% | 9 |
| GE HEALTHCARE TECHNOLOGIES I | [GEHC](https://holderbook.com/stocks/GEHC/) | $40.9M | 638,675 | 4.0% | 4 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $36.1M | 180,240 | 3.6% | 6 |
| HOME DEPOT INC | [HD](https://holderbook.com/stocks/HD/) | $35.2M | 99,919 | 3.5% | 3 |
| KT CORP | [KT](https://holderbook.com/stocks/KT/) | $33.8M | 1,955,340 | 3.3% | 3 |
| ISHARES TR | [EIDO](https://holderbook.com/stocks/EIDO/) | $33.7M | 2,983,900 | 3.3% | 4 |
| ISHARES TR | [MBB](https://holderbook.com/stocks/MBB/) | $33.0M | 349,200 | 3.3% | 3 |
| OWENS CORNING NEW | [OC](https://holderbook.com/stocks/OC/) | $29.6M | 186,324 | 2.9% | 2 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $28.4M | 68,335 | 2.8% | 3 |
| AIR PRODUCTS AND CHEMICALS I | [APD](https://holderbook.com/stocks/APD/) | $28.3M | 96,680 | 2.8% | 10 |
| ISHARES TR | [IJH](https://holderbook.com/stocks/IJH/) | $27.7M | 359,000 | 2.7% | 6 |
| AMERICA MOVIL SAB DE CV | [AMX](https://holderbook.com/stocks/AMX/) | $27.4M | 1,055,500 | 2.7% | 5 |
| MIRUM PHARMACEUTICALS INC | [MIRM](https://holderbook.com/stocks/MIRM/) | $27.2M | 232,679 | 2.7% | 5 |
| DANAHER CORP DEL | [DHR](https://holderbook.com/stocks/DHR/) | $24.1M | 126,500 | 2.4% | 4 |
| TREVI THERAPEUTICS INC | [TRVI](https://holderbook.com/stocks/TRVI/) | $22.6M | 1,213,620 | 2.2% | 4 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $21.0M | 37,360 | 2.1% | 3 |
| PROTAGONIST THERAPEUTICS INC | [PTGX](https://holderbook.com/stocks/PTGX/) | $19.7M | 160,670 | 1.9% | 5 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $18.9M | 142,083 | 1.9% | 4 |
| SPDR SERIES TRUST | [XHB](https://holderbook.com/stocks/XHB/) | $17.9M | 155,040 | 1.8% | 3 |
| JD.COM INC | [JD](https://holderbook.com/stocks/JD/) | $16.6M | 649,700 | 1.6% | 4 |
| BRIDGEBIO PHARMA INC | [BBIO](https://holderbook.com/stocks/BBIO/) | $16.3M | 219,215 | 1.6% | 3 |
| MP MATERIALS CORP | [MP](https://holderbook.com/stocks/MP/) | $15.9M | 283,050 | 1.6% | 3 |
| PDD HOLDINGS INC | [PDD](https://holderbook.com/stocks/PDD/) | $15.8M | 207,699 | 1.6% | 5 |
| SCHOLAR ROCK HLDG CORP | [SRRK](https://holderbook.com/stocks/SRRK/) | $15.7M | 285,495 | 1.6% | 4 |
| WARNER BROS DISCOVERY INC | [WBD](https://holderbook.com/stocks/WBD/) | $15.3M | 575,744 | 1.5% | 3 |
| IMMUNOME INC | [IMNM](https://holderbook.com/stocks/IMNM/) | $15.1M | 714,553 | 1.5% | 5 |
| XENON PHARMACEUTICALS INC | [XENE](https://holderbook.com/stocks/XENE/) | $15.0M | 247,765 | 1.5% | 5 |
| IREN LIMITED | [IREN](https://holderbook.com/stocks/IREN/) | $13.5M | 294,973 | 1.3% | 1 |
| KURA ONCOLOGY INC | [KURA](https://holderbook.com/stocks/KURA/) | $12.9M | 1,174,880 | 1.3% | 4 |
| BICARA THERAPEUTICS INC | [BCAX](https://holderbook.com/stocks/BCAX/) | $12.7M | 427,885 | 1.3% | 5 |
| ALEXANDRIA REAL ESTATE EQ IN | [ARE](https://holderbook.com/stocks/ARE/) | $12.6M | 238,981 | 1.2% | 4 |
| HONEYWELL INTL INC | [HON](https://holderbook.com/stocks/HON/) | $12.3M | 55,150 | 1.2% | 1 |
| HONEYWELL AEROSPACE INC | [HONA](https://holderbook.com/stocks/HONA/) | $12.2M | 55,150 | 1.2% | 1 |
| VOR BIOPHARMA INC | [VOR](https://holderbook.com/stocks/VOR/) | $11.9M | 646,550 | 1.2% | 1 |
| FLEX LTD | [FLEX](https://holderbook.com/stocks/FLEX/) | $11.7M | 72,300 | 1.2% | 1 |
| CRH PLC | [CRH](https://holderbook.com/stocks/CRH/) | $11.4M | 106,700 | 1.1% | 1 |
| SAVARA INC | [SVRA](https://holderbook.com/stocks/SVRA/) | $11.3M | 1,842,350 | 1.1% | 3 |
| CELCUITY INC | [CELC](https://holderbook.com/stocks/CELC/) | $10.9M | 103,775 | 1.1% | 3 |
| BXP INC | [BXP](https://holderbook.com/stocks/BXP/) | $8.1M | 121,924 | 0.8% | 5 |
| KILROY REALTY CORP | [KRC](https://holderbook.com/stocks/KRC/) | $7.9M | 210,800 | 0.8% | 4 |
| VAXCYTE INC | [PCVX](https://holderbook.com/stocks/PCVX/) | $7.1M | 122,930 | 0.7% | 5 |
| SL GREEN RLTY CORP | [SLG](https://holderbook.com/stocks/SLG/) | $6.9M | 132,507 | 0.7% | 3 |
| ZAI LAB LTD | [ZLAB](https://holderbook.com/stocks/ZLAB/) | $6.6M | 346,466 | 0.6% | 5 |
| ABEONA THERAPEUTICS INC | [ABEO](https://holderbook.com/stocks/ABEO/) | $5.9M | 956,770 | 0.6% | 5 |
| VORNADO RLTY TR | [VNO](https://holderbook.com/stocks/VNO/) | $5.7M | 143,800 | 0.6% | 6 |
| UNIQURE NV | [QURE](https://holderbook.com/stocks/QURE/) | $5.3M | 115,494 | 0.5% | 3 |
| CLIMB BIO INC | [CLYM](https://holderbook.com/stocks/CLYM/) | $4.7M | 360,654 | 0.5% | 5 |
| BIOCRYST PHARMACEUTICALS INC | [BCRX](https://holderbook.com/stocks/BCRX/) | $4.5M | 450,000 | 0.4% | 1 |
| EMPIRE ST RLTY TR INC | [ESRT](https://holderbook.com/stocks/ESRT/) | $4.3M | 801,300 | 0.4% | 5 |
| AVALO THERAPEUTICS INC | [AVTX](https://holderbook.com/stocks/AVTX/) | $3.5M | 189,000 | 0.3% | 3 |
| ISHARES TR | [IDV](https://holderbook.com/stocks/IDV/) | $3.2M | 77,800 | 0.3% | 4 |
| SPDR SERIES TRUST | [SPYD](https://holderbook.com/stocks/SPYD/) | $3.2M | 67,500 | 0.3% | 4 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $2.8M | 2,223,550 | 0.3% | 5 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +15.6% | +14.8% | +0.7% | 99% |
| Q1 2026 | -0.3% | -4.6% | +4.4% | 99% |
| Q4 2025 | +2.0% | +2.4% | -0.4% | 98% |
| Q3 2025 | +10.9% | +7.8% | +3.1% | 100% |
| Q2 2025 | +8.5% | +10.5% | -2.0% | 100% |
| Q1 2025 | +6.1% | -4.6% | +10.6% | 100% |
| Q4 2024 | -9.9% | +2.1% | -12.1% | 94% |
| Q3 2024 | +16.5% | +5.4% | +11.1% | 94% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.0B | 55 |
| Q1 2026 | $910.6M | 62 |
| Q4 2025 | $1.3B | 78 |
| Q3 2025 | $1.0B | 71 |
| Q2 2025 | $835.8M | 59 |
| Q1 2025 | $630.5M | 39 |
| Q4 2024 | $489.7M | 30 |
| Q3 2024 | $528.4M | 26 |
| Q2 2024 | $463.9M | 25 |
| Q1 2024 | $439.6M | 27 |
| Q4 2023 | $482.5M | 24 |
| Q3 2023 | $555.0M | 30 |